Published in Hepatitis Weekly, May 31st, 1999
"Class II molecules present antigens to CD4+ T lymphocytes, which modulate the CD8+ cytotoxic T-lymphocyte (CTL) response and are crucial to the production of neutralizing antibodies," Chloe L. Thio and colleagues wrote ("Class II HLA Alleles and Hepatitis B Virus Persistence in African Americans,"...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.